logo
How Lab-Grown Meat Could Bring An End To Needless Animal Cruelty

How Lab-Grown Meat Could Bring An End To Needless Animal Cruelty

Scoop21-04-2025

Press Release – Independent Media Institute
Lab-grown meat is a sustainable and ethical alternative to traditional meat. It offers the same taste and texture while reducing animal suffering, environmental impact, and health risks.
Billions of animals are killed each year to feed an unsustainable demand for meat. Lab-grown meat—also known as cultured, cultivated, cell-based, or clean meat—can offer a kinder alternative while still meeting the growing global demand for meat.
Silicon Valley start-ups are racing to get lab-grown meat on the market. And with good reason. Bethan Grylls of Food Manufacture, a UK-based resource for food and drink processors, reports that GovGrant, a research and development tax relief consulting firm, 'anticipates that by 2040 cultured meat will make up 35 percent of global meat consumption, with conventional meat accounting for 40 percent and vegan meat alternatives the remaining 25 percent.'
Cultured meat emerged in the early 2000s and is a miracle of modern science. Fish filets, burgers, and bacon produced in this way taste just as consumers would expect them to, but millions of animals don't need to be bred, confined, or slaughtered to create these actual meat products.
How Is Lab-Grown Meat Made?
The term 'lab-grown meat' might sound off-putting. However, labs are only involved in supporting ongoing research and development. Once they begin to produce at scale, cultured meat companies will swap out laboratories for facilities resembling microbreweries—a far cry from the industrial farms that profit from the abuse and slaughter of sentient animals.
Instead of using slaughtered animals, lab-grown meat is made by carefully removing a few muscle cells from a living animal. The pain is typically relieved with local anesthesia. The animal experiences a momentary twinge of discomfort, not unlike the feeling of getting a routine blood test at the doctor's.
Then, a lab technician places the harvested cells in bioreactors before adding them to a bath of nutrients. The cells grow and multiply, producing actual muscle tissue, which scientists shape into edible 'scaffoldings.'
These scaffoldings can transform lab-grown cells into steaks, chicken nuggets, burger patties, and fish products. National University of Singapore scientists have even begun using sorghum grain to produce cultivated pork. These offerings could sway pork eaters who are wary of parasites and disease.
The final product is an actual cut of meat, ready to be marinated, breaded, grilled, baked, or fried—no animal slaughter required! Cells from a single cow can produce an astonishing 175 million quarter-pounder burgers.
Lab-Grown Meat Is More Humane and Sustainable
Lab-grown meat is created from the same animal cells as traditional meat. The key distinction lies in the process—lab-grown meat eliminates the need for breeding, raising, and slaughtering animals, offering a more humane and sustainable alternative to conventional farming practices.
One of the most compelling aspects of lab-grown meat is its potential to reduce animal suffering. By harvesting cells without killing the animal, this innovative approach addresses the ethical concerns of consumers who oppose factory farming and industrialized slaughterhouses.
As Brian Spears, founder of New Age Meats, explains, 'People want meat. They don't want slaughter.' This sentiment reflects a growing demand for products that align with the values of compassion and sustainability without requiring individuals to give up their dietary preferences.
In addition to its ethical appeal, lab-grown meat could serve as a practical solution for meeting the global demand for meat while addressing the environmental and health challenges associated with traditional meat production. Industrial farming is a major contributor to greenhouse gas emissions, deforestation, and water pollution.
By bypassing the need for large-scale animal agriculture, lab-grown meat has the potential to significantly reduce the industry's environmental footprint. Furthermore, it can be produced under controlled conditions that minimize health risks, such as antibiotic resistance and contamination from pathogens like E. coli.
Lab-grown meat represents a revolutionary shift in how we think about food production. It merges scientific innovation with ethical and environmental consciousness, providing a tangible alternative to unsustainable practices. At the same time, it is not without challenges, such as high production costs and reliance on inevitable animal-derived by-products. Ongoing technological advancements and scaling promise to address these hurdles.
For many, enjoying real meat without traditional methods' moral and environmental consequences offers a hopeful glimpse into a future where food choices are both satisfying and responsible.
Cultured Meat Is Not Artificial
Lab-grown meat isn't artificial meat—it's real meat produced in a new, innovative way. One of the most exciting aspects of lab-grown meat is its ability to replicate the taste, texture, and appearance of conventionally produced meat. Scientists are continually refining techniques to ensure that lab-cultivated muscle tissue mimics the sensory qualities consumers expect from products like steak, chicken, and bacon. From marbled beef to flaky fish fillets, lab-grown meat offers a near-identical eating experience to traditional meat while eliminating the need for breeding, confining, and slaughtering animals. This innovation provides meat lovers with an option that aligns with their dietary preferences and ethical concerns.
Thanks to this breakthrough, consumers can enjoy the foods they already love without contributing to the cruelty and environmental damage inherent in factory farming. Lab-grown meat allows people to indulge in burgers, chicken wings, or pork chops with the peace of mind that no animal endured suffering to create their meal. As this technology scales and becomes more accessible, it can transform global food systems by providing a sustainable and humane way to meet the world's growing appetite for meat.
Healthier Alternative
Meat consumption has long been associated with health risks, mainly due to meat's high levels of cholesterol and saturated fat, which can contribute to conditions like heart disease and obesity. Traditional meat production provides little control over these factors, as the fat content of an animal's meat is determined by its diet and genetics.
However, lab-grown meat offers a unique opportunity to address these health concerns at their source. By cultivating meat in a controlled environment, food scientists can precisely regulate its nutritional composition, reducing harmful cholesterol and saturated fat levels while retaining the flavor and texture consumers expect.
This ability to engineer healthier cuts of meat could make lab-grown products a game-changer for public health. For example, lab-grown meat can be tailored to include healthier fats, such as omega-3 fatty acids, typically found in fish and known to support heart and brain health.
Additionally, lab-grown meat could mitigate the growing threat of antibiotic resistance. Since the animals are not kept in filthy factory farms or bred in painful, disease-prone ways to maximize meat production, there is far less need for antibiotic treatment. Plus, lab-grown meat is pretty resilient against bacteria like E. coli. Thus, lab-grown meat will offer new options to consumers looking for better proteins for their health, the planet, and animals. By offering a nutritionally improved and safer alternative, lab-grown meat can revolutionize how we think about meat consumption and its impact on our well-being.
Better for the Environment
Industrial animal farming significantly contributes to some of the planet's most pressing environmental issues. From climate change to deforestation and water pollution, the environmental toll of raising billions of animals for meat for a skyrocketing human population is staggering. According to the United Nations, animal agriculture accounts for 14.5 percent of the world's greenhouse gas emissions, a figure that rivals emissions from the entire transportation sector.
Industrial farming releases methane, a potent greenhouse gas, and drives deforestation to create grazing land and grow feed crops, further exacerbating the climate crisis. Lab-grown meat presents an innovative solution to these challenges by eliminating the need for large-scale animal agriculture.
One of lab-grown meat's most notable environmental benefits is its significantly lower resource footprint than that of conventional meat production. While some lab-grown meat producers currently rely on fossil fuels to power their operations, the process still uses far less land, water, and energy than raising animals on factory farms.
Cultivating meat from animal cells does not require clearing forests for pastures or growing massive quantities of feed crops. The production process not only conserves natural ecosystems but also reduces the water and fertilizer usage that often pollutes local water supplies. As production methods evolve, transitioning lab-grown meat facilities to renewable energy sources could make them even more sustainable. Studies show that producing lab-grown meat using renewable energy would have a significantly lower carbon footprint than even the most 'sustainably raised' traditional meat products.
The potential environmental benefits of lab-grown meat extend beyond reduced resource consumption. It bypasses traditional farming practices and avoids many adverse side effects associated with industrial agriculture, such as soil degradation, water contamination from animal waste, and habitat destruction.
By offering a cleaner and more sustainable way to produce meat, lab-grown meat has the potential to drastically reduce the environmental impact of meat consumption. As this technology continues to advance and scale up, it could play a critical role in mitigating climate change and preserving the planet's natural resources for future generations.
Lab-Grown Meat Is Not Vegan
Lab-grown meat is not technically vegan because it involves using cells taken from living animals. While these animals are not killed in the process, the act of harvesting cells places lab-grown meat outside the realm of purely plant-based or vegan products. However, the primary goal of lab-grown meat is not to replace vegan options but to provide a viable alternative for meat-eaters who are concerned about the ethical and environmental consequences of traditional factory farming. This innovation bridges the gap between ethical concerns and dietary preferences by offering a way to enjoy real meat without causing extensive harm to animals or the planet.
Lab-grown meat is specifically designed to appeal to consumers who might be hesitant to adopt plant-based alternatives but are nonetheless troubled by industrial agriculture practices. As Damian Carrington of the Guardian explains, 'The companies developing lab-grown meat believe this is the product most likely to wean committed meat-eaters off traditional sources.'
For many, the idea of consuming meat without contributing to animal suffering, confinement, and slaughter is a compelling proposition. Furthermore, lab-grown meat offers the potential for health benefits and a reduced environmental footprint, making it an increasingly attractive choice for ethically and environmentally conscious consumers.
While lab-grown meat still requires keeping animals in captivity, the scale of this practice is drastically smaller than that of traditional factory farming. Instead of raising thousands of animals in confined, inhumane conditions, cellular agriculture relies on small herds from which cells can be periodically harvested.
This significant reduction in the number of animals used can significantly diminish the suffering caused by meat production on a global scale. Additionally, because animals are not slaughtered, the process of harvesting cells avoids the emotional and physical trauma typically associated with traditional farming practices.
The widespread adoption of lab-grown meat could mark a turning point in how society approaches food production and animal welfare. By reducing the reliance on factory farms and minimizing the number of animals needed for meat production, lab-grown meat represents a more humane and sustainable future for food systems.
With continued technological advancements, increased public awareness, and support for ethical alternatives, the vision of lab-grown meat becoming a mainstream option could help shift global consumption patterns and pave the way for a more sustainable world.
Lab-Grown Meat Isn't Perfect
Lab-grown meat isn't perfect—yet. Some lab-grown meat is created using an animal by-product known as fetal bovine serum. Slaughterhouses obtain fetal bovine serum by collecting blood from the unborn calves of pregnant cows after they're killed.
San Francisco-based lab-grown meat producer Eat Just uses a 'very low level' serum in its chicken, the first lab-grown meat product to hit the market. In response to ethical concerns about using a slaughterhouse by-product in otherwise lab-grown meat, Eat Just is developing an animal-free alternative to fetal bovine serum.
Another controversy surrounding lab-grown meat is its price—some companies charge around $50 per serving, significantly more expensive than conventional meat. Hopefully, prices will drop as companies scale up operations, making it more accessible.
A 2024 study in Nature Food Journal projects that cultivated chicken will cost $6.20 per pound, given the proper production scale. This is competitive with the current cost of traditional organic chicken.
Lab-Grown Meat Availability
In 2020, the Singapore government approved the sale of lab-grown meats, giving consumers in Singapore the first chance to taste lab-grown chicken. But as of March 2025, lab-grown meat is not readily available to American consumers. Lab-grown meat companies are working to perfect their products, lower costs, and scale up.
More consumers worldwide should soon get their first taste of lab-grown meat. In 2023, the U.S. approved sales of lab-grown meat, though Florida and Alabama have banned the product from grocery store shelves. Tyson Foods, one of the world's ten largest meat processors, has invested millions in Future Meat Technologies, which indicates a demand for meat industry support. Until lab-grown meat hits the market, leaving animals off our plates is the kindest thing we can do.
Author Bio: Laurie Wills is the lead grassroots campaign coordinator for the Humane League UK, based in Cornwall, the United Kingdom.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Despite Being Preventable And Curable Cervical Cancer Remains 4th Biggest Cancer In Women
Despite Being Preventable And Curable Cervical Cancer Remains 4th Biggest Cancer In Women

Scoop

time5 hours ago

  • Scoop

Despite Being Preventable And Curable Cervical Cancer Remains 4th Biggest Cancer In Women

Cervical cancer (cancer of the cervix) is preventable and curable, only if it is detected early and managed effectively. Yet it is the 4th most common cancer among women worldwide, with the disease occurring in 660,000 women and claiming the lives of 350,000 women in 2022 worldwide, as per the World Health Organization (WHO). China, India, and Indonesia had the highest number of cervical cancer cases in 2022. Moreover 42% of cervical cancer cases and 39% of deaths associated with it worldwide, took place in China and India- 23% cases and 16% deaths in China, and 19% cases and 23% deaths in India. India reported over 123,000 new cases of cervical cancer and around 77,000 deaths – highest number of deaths worldwide in 2022. Cervical cancer disproportionately affects younger women, and as a result, 20% of children who lose their mother to cancer do so due to cervical cancer, says WHO. As cervical cancer is the only cancer that can be eliminated, the WHO Director General had called upon the governments in 2018 to eliminate it. All governments globally committed to do so by 2030 (by endorsing the global strategy to eliminate cervical cancer by 2030 at the World Health Assembly 2020). But despite some progress, the world is way off the mark from the elimination goal in 2025. Where cervical cancer burden is greatest, access to lifesaving services is most broken Cervical cancer reflects the global inequities between the Global North and the Global South: The highest rates of cervical cancer incidence and mortality are in low- and middle-income countries. In fact, 94% of the cervical cancer deaths in 2022 took place in these countries where access to health services is appalling. This reflects major health inequities which are driven by lack of access to vaccination, cervical cancer screening and treatment services. Prophylactic vaccination against human papilloma virus (HPV) - which is one of the most common sexually transmitted infections and which causes cervical cancer - and screening, and treatment of pre-cancer lesions are very cost-effective strategies to prevent cervical cancer. WHO's call to deliver on #HealthForAll dates to the 1970s, but even now gaping health inequities and injustices plague the health systems – especially in the Global South. Vaccines against HPV have existed since almost 20 years now. No surprise for guessing that both Cervarix (made by Glaxo) and Gardasil (made by Merck) were made in the rich nations – and their rollout in the Global South has been far from ideal. In 2022, India-based Serum Institute in collaboration with the Department of Biotechnology of the government of India developed India's first indigenously produced HPV vaccine called Cervavac. So, now there is a vaccine developed in the Global South too. But its rollout is far from ideal as of now. It is still not a part of India's public health programme, for instance. Same inequities block access to HPV screening in the Global South "Almost all cervical cancers (~95%) are caused by persistent HPV infection. Women living with HIV are 6 times more likely to develop cervical cancer compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV,' said Dr Kuldeep Singh Sachdeva, former head of Indian government's national TB and HIV programmes. Dr Sachdeva was speaking at the National Dialogue and stakeholder meet organised by National Coalition of People living with HIV in India (NCPI Plus) bringing together over 100 community leaders from almost all states of India. Dr Sachdeva currently leads Molbio Diagnostics as President and Chief Medical Officer. He was speaking ahead of 10th Asia-Pacific AIDS & Co-Infections Conference (APACC 2025), Japan; 2nd Asia Pacific Conference on Point of Care Diagnostics for Infectious Diseases (POC 2025), Thailand; and 13th International AIDS Society Conference on HIV Science (IAS 2025), Rwanda. Cervical cancer screening efforts in most settings of the Global South have long been hampered by reliance on outdated methods like pap smears and visual inspection with acetic acid (VIA) test, both of which suffer from poor sensitivity, high subjectivity, and dependence on specialised infrastructure. Advanced molecular HPV tests developed by the Global North, while highly accurate than pap smear and VIA, remain inaccessible for most women living in peripheral, rural, and resource-limited settings, especially of the Global South. India's first point-of-care HPV test that can be deployed at point-of-need in the Global South In April 2025, India's first ever indigenously developed RT-PCR molecular test for HPV on Truenat (called HPV-HR Plus) got an independent multi-centric validation done by Government of India's Department of Biotechnology, Biotechnology Industry Research Assistance Council (BIRAC) and Grand Challenges India. Truenat HPV-HR Plus test is made by Molbio Diagnostics in India. This independent validation of Truenat HPV-HR Plus was conducted under the study 'Validating Indigenous Human Papilloma Virus (HPV) Tests for Cervical Cancer Screening in India.' The study involved leading Indian government's research institutes, including All India Institute of Medical Sciences (AIIMS) Delhi, ICMR National Institute for Cancer Prevention and Research (NICPR) Noida, and ICMR National Institute for Research in Reproductive and Child Health (NIRRCH) Mumbai, in collaboration with WHO's International Agency for Research on Cancer (IARC). There are over 200 genotypes of HPV but those that put the infected person at risk of developing cervical cancer are few. Truenat HPV-HR Plus molecular test enables detection for 8 HPV high-risk genotypes – which account for over 96% cervical cancer cases worldwide. These HPV high-risk genotypes include 16, 18, 31, 33, 35, 45, 52 and 58. Out of these, 16 and 18 high-risk genotypes dominate globally as 77% of invasive cervical cancer cases are associated with them. These high-risk genotypes can also cause cancer of the anus, penis, vagina, vulva, and oropharynx (throat). Raising cervical cancer awareness and health literacy among people with HIV As women living with HIV are 6 times more at risk of cervical cancer, communities and networks of people with HIV must come forward to find ways to integrate cervical cancer screening as well as for other cancers (such as breast cancer) programmatically and in people-centred manner, said Daxa Patel, co-founder of National Coalition of People living with HIV in India (NCPI Plus) and its former President. Agrees Pooja Mishra, Secretary of NCPI Plus that it is unacceptable when cervical cancer, which is preventable and curable - and the only cancer which can be eliminated - still kills 350,000 women worldwide. We also need to raise awareness, health and treatment literacy among the young people, said Mishra. That is why NCPI Plus took leadership in organising a national dialogue and stakeholder consultation on preventing cancers among people with HIV, especially women. Truenat HPV-HR Plus test is critical for closing the screening gap, particularly for asymptomatic women and women who are at higher risk for persistent HPV infection. By shifting HPV screening closer to the most-at-risk people and communities, this test ensures early detection, better triaging, and timely treatment - especially in historically underserved populations. Over 10,000 Truenat RT-PCR molecular test machines are already deployed globally in over 85 countries (mostly for TB), and mostly in the Global South nations in remote settings. Truenat is a battery operated (with solar power charging), laboratory independent, de-centralised and point-of-care test that provides highly accurate diagnosis for over 30 diseases (including TB, HPV, HCV, HBV, STIs, COVID-19, etc) within an hour – thus enabling same day test and treat, counselling and follow-up. Superiority of Truenat HPV-HR Plus test Older Pap smear test detects precancerous or cancerous cervical cancer cells whereas Truenat HPV-HR Plus test detects the presence of high-risk HPV DNA (8 genotypes). Pap smear is a cytological screening test and depends on the observing medical expert's skill and slide quality, whereas Truenat is a PCR-based nuclear acid amplification test with very high sensitivity and specificity. False negative reports are higher and false positive reports are also moderate when pap smear is used whereas both are low with Truenat HPV-HR Plus. The most recent validation of Truenat HPV-HR Plus showed 100% specificity and 100% sensitivity. Truenat HPV-HR is designed to work with cervical swab samples collected by a clinician (self-collection of samples is still under evaluation), and it gives highly accurate results in just 60 minutes. Whereas, a pap smear results may take 3-7 days as these are laboratory dependent. Easy to use and with high stability at room temperature, Truenat HPV-HR Plus requires minimal biosafety and is optimised for use at both the laboratory and near-patient settings. This test overcomes shortcomings of current diagnostic methods, including variable sensitivity and specificity, high costs, complex workflows, and dependence on advanced equipment, said Dr Sachdeva. Highlighting the importance of developing health technologies in the Global South, Rajesh S Gokhale, Secretary, Department of Biotechnology, Ministry of Science and Technology, Government of India said, 'Truenat HPV-HR Plus represents the kind of diagnostic innovation we need - dependable, scientifically rigorous, locally developed, and built to serve our public health system. It is a huge step forward in strengthening cervical cancer screening across India.' "HPV infection is common. However, persistence of HPV infection could be deadly. Studies show that nearly half of persistent HPV infections do not resolve by 24 months. These silent carriers drive the progression to high-grade pre-cancerous lesions and cancer. That's why extended HPV genotype detection is crucial," shared Dr Sachdeva. HPV also causes oropharyngeal cancers Oropharyngeal cancers related to HPV vary from 28% to 68% in the richer nations. Indian studies also show alarming numbers though, more research is needed for science-informed responses towards eliminating HPV related cancers in our population, said Dr Ishwar Gilada, President Emeritus of AIDS Society of India (ASI) and Governing Council member of International AIDS Society (IAS). 'While there is increasing evidence of HPV-associated oropharyngeal cancer in both men and women globally, there still remain gaps in gender-neutral HPV vaccination policies globally,' said Dr Sachdeva. Community leaders like Manoj Pardeshi, who is among the co-founders and inspiring lights of NCPI Plus, said that regardless of gender, all those eligible and at risk of HPV related cancers, must be vaccinated against HPV. Programme addressing cervical cancer elimination should expand to eliminate all HPV related cancers in people-centred ways, regardless of gender. HPV is transmitted through: - Sexual contact: Transmission mode is through vaginal, anal, or oral sex with an infected person. - Skin-to-skin contact: Transmitted through non-penetrative sexual activities involving skin-to-skin contact. The WHO Guidelines recommend HPV detection via molecular test after age of 30 (and every 5 years thereafter). Vaccination against HPV is highly recommended for younger people under the age of 15 or before the initiation of sexual activity. Do not leave equity behind 'Truenat HPV-HR Plus test is about equity in detection. By expanding beyond traditional targets, we reach the genotypes that matter more in our populations for cervical cancer elimination. This means earlier intervention, fewer missed cases, and better outcomes,' said Dr Sachdeva. Truenat HPV-HR Plus offers the best of both worlds - critical genotype coverage and real-world deploy-ability. What does it mean to eliminate cervical cancer by 2030? To eliminate cervical cancer, all countries must reach and maintain an incidence rate of below 4 per 100,000 women. Achieving that goal rests on three key pillars and their corresponding targets: vaccination: 90% of all eligible young people must be fully vaccinated with the HPV vaccine by the age of 15. screening: 70% of women should be screened using a high-performance test by the age of 35, and again by the age of 45; treatment: 90% of women with pre-cancer treated and 90% of women with invasive cancer managed. No other cancer but cervical cancer is fully preventable and curable if detected and managed early. Even one death from it is a death too many. Shobha Shukla – CNS (Citizen News Service) (Shobha Shukla is the award-winning founding Managing Editor and Executive Director of CNS (Citizen News Service) and is a feminist, health and development justice advocate. She is a former senior Physics faculty of prestigious Loreto Convent College and current Coordinator of Asia Pacific Regional Media Alliance for Health and Development (APCAT Media) and Chairperson of Global AMR Media Alliance (GAMA received AMR One Health Emerging Leaders and Outstanding Talents Award 2024). She also coordinates SHE & Rights initiative (Sexual health with equity & rights). Follow her on Twitter @shobha1shukla or read her writings here

Nutritionist Claire Turnbull
Nutritionist Claire Turnbull

RNZ News

time4 days ago

  • RNZ News

Nutritionist Claire Turnbull

Wellbeing expert Claire Turnbull is known for her practical advice for those wanting to make positive health and lifestyle changes. Originally from the UK, she leads a team of experts through her private practice Mission Nutrition, and is also a sought-after speaker, columnist and book author. For the first time, Claire is now opening up about her own struggles with food and her post-natal anxiety. In her new book, End Your Fight with Food she shares her lifetime battle with disordered eating, depression and anxiety. Claire Turnbull joins Kathryn Ryan. To embed this content on your own webpage, cut and paste the following: See terms of use.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store